Browse By: Country ι Category ι Tag

OpportunityAnalyzer: Axial Spondyloarthritis - Opportunity Analysis and Forecast to 2024 - Event-Driven Update

Pages » 199
Published By » GlobalData
Price » $10995
In stock
View Report Details
Description

OpportunityAnalyzer: Axial Spondyloarthritis - Opportunity Analysis and Forecast to 2024 - Event-Driven Update Summary Ankylosing Spondylitis (AS) is an autoimmune disease that causes inflammation of the sacroiliac joint accompanied by pain and stiffness of the lower back, which typically gets better with exercise. Ankylosis (fusion) of the spine is typically a late-stage complication and has been nicknamed bamboo spine, due to its appearance on X-ray. It is now recognized that the pathological changes leading to ankylosis develop over time, and an early stage of the disease, known as non-radiographic axial spondyloarthritis (nr-axSpA) is characterized by the same symptoms of inflammatory ... Click here for more details


Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
GBI Research’s report, “Musculoskeletal Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First-in-class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis, provides in-depth analysis of unmet needs, drivers and barriers t
Published Date: Oct 2010
Price: $3500
Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
GBI Research’s new report, “Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global hepatitis therapeutics
Published Date: Oct 2010
Price: $3500
Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate
GBI Research, the leading business intelligence provider, has released its latest research, Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate, which provides insights into anti-inflammatory therapeutics revenue forecasts until 2017. The repor
Published Date: Oct 2011
Price: $3500
Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released a new report, Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global rheumatoid arthritis (RA) market. The report identifies the key trends shaping
Published Date: Nov 2010
Price: $2000
Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
GlobalData, the industry analysis specialist, has released its new report, Juvenile Rheumatoid Arthritis (JRA) Therapeutics Pipeline Assessment and Market Forecasts to 2017. The report is an essential source of information and analysis on the global JRA therapeutics market. The report identifies the
Published Date: Jul 2011
Price: $2000
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
GlobalData, the industry analysis specialist, has released its new report, Rheumatoid Arthritis Therapeutics Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global rheumatoid arthritis therapeutics market. The report identifies t
Published Date: Sep 2011
Price: $3500
Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014
GBI Research, the leading business intelligence provider, has released its latest report, “Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 2014”. The report is built using data and information sourced from p
Published Date: Jan 2012
Price: $3500
Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
Arthritis Therapeutics Market to 2018 Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications Summary GBI Research’s new report, Arthritis Therapeutics Market to 2018 Novel Oral JAK Inhibitors and Biolog
Published Date: May 2012
Price: $3500
The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst
GlobalData's analysis alert "The Rheumatoid Arthritis Community is Swelling with Anticipation as its Research Pipeline Begins to Burst, analyzes the current pipeline for rheumatoid arthritis drug therapeutics. In addition to the anticipated upcoming approval of Pfizers tofacitinib, the pipeline
Published Date: Jun 2012
Price: $995
Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019
GlobalData, the industry analysis specialist, has released its new report, Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Osteoarthritis Pain Therapeutics market. The report identif
Published Date: Jun 2012
Price: $3995

 


 

Related News

Hygiene Hypothesis Corroborates Spike in Demand for Allergy Diagnostics
The global allergy diagnostic market has been booming over the past few years due to a proposed hygiene hypothesis. The theory claims that lack of exposure to allergens and dust or living in excessively hygienic conditions can make the human body prone to allergies as the immune system does not learn to fight. This theory has been proposed to back the increasing number of asthma cases amongst children, especially in the developed countries, where hygiene is given importance above its due. In add
Date: Oct 24

Globally Warming to Encourage Spread of Lethal Bacteria in Oceans Globally
It has already become evident that the increasing ocean temperatures have been making individuals sick and this is only becoming worse now. The bacteria that loves warmth is now growing in large numbers and is posing disastrous impacts on the human health, as per a study published recently. The bacteria called as Vibrio bacteria has caused around eighty thousand illnesses as well as about hundred deaths within the U.S alone in the past few years. Exceptional Count of Vibrio Cases in Northern Eu
Date: Aug 10

Global Paracetamol and PAP Market Fights an Uphill Battle
Paracetamol has been one of the most commonly used drugs in modern medicine. It has been used in the treatment of the most common ailments, including fever, cold, arthritis, and also major epidemics such as the swine flu. Consumers have shown a high rate of consumption of paracetamol as it provides almost instant relief from symptoms, is available everywhere as a generic drug, and is available as an over the counter drug in most countries. This includes the nations in North America, where the co
Date: Feb 18

Next-generation Antifungal Drugs Hold Promise for Dermatophytoses, Newer Therapeutics Overcome Shortcomings of Early Drugs
In the U.S., onychomycosis poses as a major public health problem, as it is prevalent in 10% of the population and its associated morbidity. Although not life-threatening, the fungal infection is a dermatophytic invasion of the nail plate. The infection can be present in any component of the nail unit, which includes the bed, matrix, or plate. Pain, discomfort, and disfigurement are the notable signs of onychomycosis, which may lead to significant physical and occupational limitations. The condi
Date: Jan 25

Despite Rise in Number of Erectile Dysfunction Cases, Revenue Generation from ED Drugs to Decline
This is probably one of the few times when availability of certain drugs is actually hampering the growth of a certain section of the health care market. The erectile dysfunction drugs market, over the past few decades, has been driven by the rising incidence of erectile dysfunction caused by environmental and genetic factors. However, there are several forces in the coming years that are anticipated to negatively impact the erectile dysfunction drugs market, causing it to register a -4.50 per c
Date: Jan 22

Chipotle and Costco E.coli Outbreaks Point out the Need for Advanced Testing Kit
During the period from October 2015 to November 2015, over 50 customers have been affected with E.coli after eating at Chipotle locations across Washington, Kansas, Oregon, and Oklahoma. More recently, 80 college students in Boston fell sick with the norovirus after contracting it from a single Chipotle location. By the end of 2015, more than 350 people became sick after eating at Chipotle. In early November, just after the Chipotle case had made headlines, another E.coli outbreak was reported i
Date: Jan 20

What the Newly Found Ebola Antibodies Mean for the Healthcare Industry
In what could be perceived to be one of the greater breakthroughs in the field of medicine, researchers have engineered the first antibodies that have the ability to neutralize two strains of the deadly Ebola-causing virus. The research was conducted on mice and is considered to be a major step in achieving immunization against all strains of Ebola. The research was led by Dr. Jonathan Lai. He stated that it is a tremendous advance to achieve a broadly effective Ebola immunotherapy. This is bec
Date: Jan 14

California Considering Exempting ‘Tampon Tax’
Growing awareness towards sanitation and urbanization has boosted the demand from the global feminine hygiene products market. In regions, especially Asia Pacific, several health programs focussed to raise awareness about sanitation across rural areas has augmented the market growth. Key market players such as Proctor & Gamble and Johnson & Johnson have partnered with governments in countries such as India to increase awareness among women regarding menstruation related health concerns. Rising c
Date: Jan 12

Aurobindo Pharma Latest to Join Line of Generic Drug Makers of Norethindrone Acetate
The United States Food and Drugs Association has officially given the nod of approval to Aurobindo Pharma to manufacture, sell, and market generic variants of norethindrone acetate within the U.S. market. The U.S. health regulator has provided Aurobindo Pharma with the vital agreement to create 5 mg strength tablets of norethindrone acetate, as said by an Aurobindo Pharma spokesperson in a recent statement. They later added that the drug has an estimated market size of US$42 mn for the twelve m
Date: Jan 11

Oral Contraceptive Pills Market Witnessing Surging Demand Particularly from Developed Regions
The market segment of oral contraceptive pills in the pharmaceutical industry is gearing to exhibit an exponential growth in the near future. The latest market studies published reveal promising growth prospects for the niche is very promising particularly due to the rising awareness about the pregnancy preventive methods, their corresponding benefits, and favorable reimbursement policies introduced by the policy makers.  Among the most prominent brands available in the market Loestrin and Bay
Date: Jan 07

Upcoming Reports

Rheumatoid Arthritis Pharmacotherapeutics Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
Treatment options for rheumatoid arthritis (RA) are expanding as a result of increasing research activities and more explicit understanding of the pathophysiology of diseases. For the treatment of RA, novel selective inhibitors such as cyclooxygenase-2 (COX-2) are used along with the non-steroidal
Published By: Transparency
Price: $5795
Prescription Arthritis Treatments Market: Singapore and Indonesia, Market Size, Growth and Industry Analysis
METHODOLOGY  Our research consists of both secondary and primary research with later constituting the greater portion. We also have a large internal repository and access to a number of external proprietary databases to help address specific requirements of our clients. The research proc
Published By: Transparency
Price: $5795
Psoriatic Arthritis Pharmacotherapy Market - Global Industry Analysis, Size, Share And Forecast, 2012 - 2018
Psoriatic Arthritis is a type of rheumatoid arthritis which mainly affects fingers and toes followed by psoriasis. Moreover, a condition in which person has both psoriasis and arthritis is identified to have suffered from psoriatic arthritis. Major symptom for psoriatic arthritis is associated wit
Published By: Transparency
Price: $5595
Pipeline Review Of Rheumatoid Arthritis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease. The cause of rheumatoid arthritis is not known. The joint inflammation of rheumatoid arthritis causes swelling, pain, stiffness and redness in the joints. It can lead to a significant loss of mobility due to pain and joint destr
Published By: Transparency
Price: $5795